C12N 2310/16
Aptamers
C12N2310/16 (Aptamers) appears on 1,304 US grants and 2,329 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,304
- Published applications
- 2,329
- Assignees
- 826
- Inventors
- 3,478
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 2 |
| 2003 | 1 | 8 |
| 2004 | 0 | 15 |
| 2005 | 1 | 17 |
| 2006 | 3 | 29 |
| 2007 | 1 | 18 |
| 2008 | 6 | 20 |
| 2009 | 12 | 53 |
| 2010 | 13 | 32 |
| 2011 | 16 | 51 |
| 2012 | 20 | 69 |
| 2013 | 30 | 68 |
| 2014 | 35 | 72 |
| 2015 | 59 | 109 |
| 2016 | 62 | 138 |
| 2017 | 76 | 149 |
| 2018 | 107 | 163 |
| 2019 | 158 | 203 |
| 2020 | 139 | 180 |
| 2021 | 118 | 186 |
| 2022 | 97 | 214 |
| 2023 | 88 | 164 |
| 2024 | 90 | 142 |
| 2025 | 84 | 139 |
| 2026 | 71 | 88 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Riboswitch modulated gene therapy for retinal diseases29 Sep 2026US 12,747,441 B2The Medical College of Wisconsin, Inc.
- RNA molecules, methods of producing circular RNA, and treatment methods15 Sep 2026US 12,737,877 B2Cornell University
- Methods of reducing or preventing clostridioides difficile colonization18 Aug 2026US 12,708,119 B2Liv Process, Inc.
- Methods of treating schizophrenia and other neuropsychiatric disorders18 Aug 2026US 12,708,608 B2University of Copenhagen
- Regulation of von Willebrand factor (VWF)18 Aug 2026US 12,709,754 B2Band Therapeutics, LLC
- Modular platform for molecular conjugation8 Oct 2026US 2026/0306645 A1CamBrixBio Ltd
- Materials and methods for aptamer selection8 Oct 2026US 2026/0308599 A1The Penn State Research Foundation
- Dna aptamer capable of selectively binding to soluble flt-1 and carrier having said dna aptamer immobilized thereto8 Oct 2026US 2026/0308600 A1Tagcyx Biotechnologies
- Multiple measurements using an electrochemical aptamer-based sensor1 Oct 2026US 2026/0297592 A1The University of Melbourne
- Compositions, Methods, and Systems for Genomic Editing24 Sep 2026US 2026/0286329 A1Intellia Therapeutics, Inc.
Most cited
By later US patents
- CRISPR enzymes and systems331US 9,790,490 B2Massachusetts Institude of Technology · 2017
- Nucleic acid ligands of tissue target118US 6,127,119 ANeXstar Pharmaceuticals, Inc. · 2000
- Nucleic acid molecules with specific recognition of native PrPSc, production and use109US 7,371,833 B12008
- Systematic evolution of ligands by exponential enrichment: tissue selex104US 5,712,375 ANeXstar Pharmaceuticals, Inc. · 1998
- Nucleic acid ligands that bind to and inhibit DNA polymerases100US 6,020,130 ANeXstar Pharmaceuticals, Inc. · 2000